Shanghai Shuixing Home Textile Co Ltd Class A (603365.SS) stock: key figures, P/E, revenue and dividend
Consumer Discretionary · Textiles · China · ISIN CNE100002TJ2
Shanghai Shuixing Home Textile Co Ltd Class A financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 4.19 bn CNY | 4.53 bn CNY |
| Gross profit | 1.71 bn CNY | 2.04 bn CNY |
| Operating income | 426.20 m CNY | 475.56 m CNY |
| EBIT | 446.71 m CNY | 478.61 m CNY |
| Net income | 366.62 m CNY | 406.83 m CNY |
| Diluted EPS – continuing operations | 1.40 CNY | 1.55 CNY |
Full history since 2013, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Shanghai Shuixing Home Textile Co Ltd Class A
Shanghai Shuixing Home Textile Co., Ltd., together with its subsidiaries, engages in the research, design, development, production, and sale of home textile products in China and internationally. The company offers comforters, bedding sets, quilts, pillow cores, single-piece combinations, cushions, children's products, summer products, blankets, and other bedding products, as well as household goods. It sells its products under the Mercury Home Textiles, Mercury STRAZ HOME, Belles Home Textiles, Mercury Kids, BLISS, SHUIXING KIDS, and MERCURY BABY brands. Shanghai Shuixing Home Textile Co., Ltd. was founded in 1987 and is headquartered in Shanghai, China.
More stocks
- Oeneo SA (SBT.PA)
- Tianjin Jiuri New Materials Co Ltd (688199.SS)
- Centrotec Se (CEV.HM)
- Hangzhou Minsheng Healthcare Co Ltd (301507.SZ)
- GIGAVIS LTD (PROPOSED) (420770.KQ)
- Chong Kun Dang Pharmaceutical (185750.KS)
- Hangzhou AGS MedTech Co. Ltd. A (688581.SS)
- Aclaris Therapeutics, Inc. (ACRS)
- Mengtian Home Group Inc. (603216.SS)
- Beijing ZznodeTechnologies Co Ltd (003007.SZ)
- Mensch und Maschine Software (MUM.DE)
- FIRST BUSINESS FINANCIAL SERVICES, INC. (FBIZ)
Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.